Navigation Links
Experts cite 'misconceptions' on brain metastases

June 24, 2014 "Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Dr. Douglas Kondziolka of NYU Langone Medical Center and coauthors identify some issues that may be standing in the way of optimal clinical management for patients with cancer that has spread to the brain from other sites.

'All Brain Metastases Are Created Equal'and Other Misconceptions

Brain metastases are an important problem in cancer treatment, but one for which there are relatively few well-designed clinical trials. That partly reflects an "often nihilistic" viewpoint, given that survival is relatively short for many patients with brain metastases.

But a few key studies provide answers to some important questions on the benefits of specific treatments. At a time of rapid progress in cancer care, Dr. Kondziolka and colleagues highlight five misconceptions that, in their view, must be overcome to advance treatment for patients with brain metastases.

The first misconception is assuming that "all histologies are created equal"that the type of cancer doesn't matter once it has spread to the brain. Historically, studies have included any and all patients with brain metastases. But that may overlook important differences between brain metastases from different types and sites of cancerfor example, lung cancer, breast cancer, or malignant melanoma.

Likewise, there's no basis for the assumption that the number of brain metastases is the sole factor determining patient outcome. Rather, Dr. Kondziolka and coauthors believe the focus should be on the total tumor burden, including the size as well as the number of metastases.

Similarly, some doctors hold the misconception that there's no such thing as a single metastasisthat if one lesion is present, there must be others as well. But that's contrary to strong evidence that treatment for single brain metastases can improve tumor control and patient survival.

Doctors may also believe that treatment with whole-brain radiation therapy (WBRT) inevitably leads to declines in cognitive (intellectual) function. Dr. Kondziolka and coauthors emphasize that, as for any treatment, the risks and benefits of WBRT must be considered for each individual patient. Studies are underway to clarify the cognitive effects of WBRT, with the goal of balancing cognitive functioning with tumor control.

Finally, there's an outdated assumption that since most brain metastases are symptomatic, there's no major benefit of screening tests for early detection. But with increased use of magnetic resonance imaging, metastases are now being detected before they cause any symptoms. Previous studies of larger, symptomatic metastases may not apply to these smaller, asymptomatic lesions.

"Especially in this era of increasingly personalized medicine, one-size-fits-all thinking is improper, especially for a diagnostic entity as wide and varied as brain metastasis," Dr. Kondziolka and coauthors write. Their article includes some recommendations for future trials of brain metastases, including patient-related factors, such as the need for formal measurement of cognitive function; and tumor-related factors, such as studies focusing on a single tumor type and considering the total tumor burden.


Contact: Connie Hughes
Wolters Kluwer Health

Related medicine news :

1. Citing urgent, acute mental health issues, especially in Africa, experts petition govts to act
2. Experts recommend blood, urine testing to diagnose rare adrenal tumors
3. Nutrition experts: Debate over value of vitamin, mineral supplements is far from over
4. Nationally-recognized health policy researchers and experts convene in San Diego June 8-10
5. Could cannabis curb seizures? Experts weed through the evidence
6. Experts question routine mammograms in elderly
7. Eye health experts come together to boost fight against avoidable blindness
8. Sacramento Acupuncture Experts Tian Chao Herbs and Acupuncture Help Customers Stay Healthy With Herbal Medicine, Traditional Chinese Medicine, and Acupuncture
9. Pediatric HIV/AIDS experts to present at 17th Intl Conference on AIDS and STIs in Africa
10. Nutrition experts explore dietary approaches that influence type 2 diabetes risk
11. Quality of Healthcare Experts Continue To Try To Put A Square Peg Into A Round Hole
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
Breaking Medicine Technology: